These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 12721332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
    Zhao R, Pollack GM.
    Biochem Pharmacol; 2009 Oct 15; 78(8):1052-9. PubMed ID: 19523457
    [Abstract] [Full Text] [Related]

  • 3. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P, Sasongko L, Link JM, Mankoff DA, Muzi M, Collier AC, Unadkat JD.
    J Pharmacol Exp Ther; 2006 May 15; 317(2):704-10. PubMed ID: 16415090
    [Abstract] [Full Text] [Related]

  • 4. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
    Hendrikse NH, Schinkel AH, de Vries EG, Fluks E, Van der Graaf WT, Willemsen AT, Vaalburg W, Franssen EJ.
    Br J Pharmacol; 1998 Aug 15; 124(7):1413-8. PubMed ID: 9723952
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
    Dagenais C, Zong J, Ducharme J, Pollack GM.
    Pharm Res; 2001 Jul 15; 18(7):957-63. PubMed ID: 11496955
    [Abstract] [Full Text] [Related]

  • 8. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
    Smith BJ, Doran AC, McLean S, Tingley FD, O'Neill BT, Kajiji SM.
    J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1252-9. PubMed ID: 11504828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T.
    Drug Metab Dispos; 2011 Jan 15; 39(1):8-14. PubMed ID: 20962062
    [Abstract] [Full Text] [Related]

  • 11. Role of P-170 glycoprotein in colchicine brain uptake.
    Drion N, Risede P, Cholet N, Chanez C, Scherrmann JM.
    J Neurosci Res; 1997 Jul 01; 49(1):80-8. PubMed ID: 9211992
    [Abstract] [Full Text] [Related]

  • 12. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
    Kallem R, Kulkarni CP, Patel D, Thakur M, Sinz M, Singh SP, Mahammad SS, Mandlekar S.
    Drug Metab Lett; 2012 Jun 01; 6(2):134-44. PubMed ID: 23061481
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L, Zhao C, Yan M, Zhang LY, Xia YZ.
    Phytother Res; 2009 Jul 01; 23(7):933-7. PubMed ID: 19172664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH, de Vries EG, Eriks-Fluks L, van der Graaf WT, Hospers GA, Willemsen AT, Vaalburg W, Franssen EJ.
    Cancer Res; 1999 May 15; 59(10):2411-6. PubMed ID: 10344751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect.
    Padowski JM, Pollack GM.
    Brain Res; 2011 Dec 02; 1426():1-17. PubMed ID: 22036081
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
    Hamabe W, Maeda T, Fukazawa Y, Kumamoto K, Shang LQ, Yamamoto A, Yamamoto C, Tokuyama S, Kishioka S.
    Pharmacol Biochem Behav; 2006 Nov 02; 85(3):629-36. PubMed ID: 17134744
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.